Ireland
--:--IST
Priya Life Science Sponsor trial record
Sponsor · clinical trials

University Hospital of Mont-Godinne clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Belgium register with University Hospital of Mont-Godinne as lead sponsor. Synced 16 Nov 2026
7Current trials
5Recruiting now
0Drugs in these trials
1Trial register
At a glance

University Hospital of Mont-Godinne is the lead sponsor of 7 current clinical trials in our Belgium register. 5 are recruiting patients now. All registered phases are Not applicable. The most-studied condition is Healthy Individuals (Controls).

ClinicalTrials.gov trials by status

  • Recruiting571%
  • Active, closed229%

Trials by phase

  • Not applicable7100%
01

Clinical trials sponsored by University Hospital of Mont-Godinne

7 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
Exploring Motor Learning in Acute Stroke Through Robotics
NCT04171856 · ClinicalTrials.gov ↗ · Stroke, Acute
Not applicable Recruiting 2020-01 Belgium
Bimanual Motor Skill Learning Through Robotics in Stroke Survivors and Healthy Individuals
NCT03974750 · ClinicalTrials.gov ↗ · Stroke
Not applicable Recruiting 2017-07 Belgium
Bimanual Motor Skill Learning in Acute Stroke
NCT05760846 · ClinicalTrials.gov ↗ · Stroke, Acute, Stroke, Subacute
Not applicable Recruiting 2023-04 Belgium
Inter-Limb Transfer in Acute Stroke
NCT07822633 · ClinicalTrials.gov ↗ · Stroke, Acute, Stroke (Subacute), Healthy Individuals (Controls)
Not applicable Recruiting 2026-08 Belgium
Unimanual Versus Bimanual Motor Skill Learning in Acute and Chronic Stroke
NCT07826832 · ClinicalTrials.gov ↗ · Acute Stroke, Chronic Stroke Patient, Healthy Individuals (Controls)
Not applicable Recruiting 2026-05 Belgium
Bimanual Motor Skill Learning Through Robotics in Chronic Cerebellar Stroke Survivors and Healthy Individuals
NCT04642599 · ClinicalTrials.gov ↗ · Chronic Cerebellar Stroke, Healthy Individuals (Controls)
Not applicable Active, closed 2021-01 Belgium
Mechanical and Sensorial Training in the Olfactive Rehabilitation of Patients With Total Laryngectomy
NCT07122037 · ClinicalTrials.gov ↗ · Cognitive Aging, Hyposmia, Total Laryngectomy
Not applicable Active, closed 2021-09 Belgium

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in University Hospital of Mont-Godinne trials

12 conditions
Healthy Individuals (Controls)3Stroke, Acute3Stroke (Subacute)2Chronic Cerebellar Stroke1Stroke1Stroke, Subacute1Cognitive Aging1Hyposmia1Total Laryngectomy1Chronic Stroke Patients1Acute Stroke1Chronic Stroke Patient1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Belgium75

A trial with sites in more than one country appears in each of those registers.

04

Questions about University Hospital of Mont-Godinne trials

How many clinical trials does University Hospital of Mont-Godinne sponsor?

University Hospital of Mont-Godinne is the lead sponsor of 7 current trials on ClinicalTrials.gov in our Belgium register, as of the registry sync on 16 November 2026. Completed and withdrawn studies are not counted.

Are University Hospital of Mont-Godinne trials recruiting?

Yes. 5 of its 7 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 16 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.